Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin

Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses

Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615 · see citing works

Analyzing real-time PCR data by the comparative CT method

Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · see citing works

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799 · see citing works

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · see citing works

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814 · see citing works

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · see citing works

NAFLD: A multisystem disease

Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,082 · see citing works

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · see citing works

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · see citing works

Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578 · see citing works

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569 · see citing works

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · see citing works

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035 · see citing works

Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound

Tracy, L. E., Minasian, R. A., & Caterson, E. J. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0561 · Cited by 1,008 · see citing works

Hepatic inflammation and fibrosis: Functional links and key pathways

Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972 · see citing works

Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes

Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · see citing works

Pathobiology of liver fibrosis: a translational success story

Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894 · see citing works

Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding

Tripathi, S., Pohl, M. O., Zhou, Y., Rodríguez-Frandsen, A., Wang, G., Stein, D. A., Moulton, H. M., DeJesus, P., Che, J., Mulder, L. C. F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.11.002 · Cited by 846 · see citing works

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762 · see citing works

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727 · see citing works

From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

Wree, A., Broderick, L., Canbay, A. E., Hoffman, H. M., & Feldstein, A. E. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.149 · Cited by 608 · see citing works

Oxidative and reductive metabolism by cytochrome P450 2E1

Koop, D. R. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1537462 · Cited by 561 · see citing works

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554 · see citing works

Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease

Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R. J., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483 · see citing works

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: Hepatology

Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414 · see citing works

Clinical evidence for the regression of liver fibrosis

Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411 · see citing works

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410 · see citing works

Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

Murphy, S. K., Yang, H., Moylan, C. A., Pang, H., Dellinger, A., Abdelmalek, M. F., Garrett, M. E., Ashley–Koch, A., Suzuki, A., Tillmann, H. L., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.047 · Cited by 391 · cited 1× · see citing works

Distinct but complementary contributions of PPAR isotypes to energy homeostasis

Dubois, V., Eeckhoute, J., Lefèbvre, P., & Staels, B. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88894 · Cited by 385 · see citing works

Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

Machado, M. V., Michelotti, G. A., Xie, G., Pereira, T. A., Boursier, J., Bohnic, B., Guy, C. D., & Diehl, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127991 · Cited by 381 · see citing works

Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.

Haas, J., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 372 · see citing works

Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

Satapathy, S. K., & Sanyal, A. J. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562943 · Cited by 372 · see citing works

PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis

Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefèbvre, P., Taskinen, M., Hul, W. V., Mertens, I. L., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.019 · Cited by 357 · see citing works

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids

Arendt, B. M., Comelli, E. M., David, W. L., Lou, W. Y. W., Teterina, A. A., Kim, T., Fung, S. K., Wong, D., McGilvray, I. D., Fischer, S. E., et al. (2015) · Hepatology · doi:10.1002/hep.27695 · Cited by 335 · see citing works

Sinusoidal communication in liver fibrosis and regeneration

Marrone, G., Shah, V. H., & Gracia‐Sancho, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.018 · Cited by 324 · see citing works

Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

Moylan, C. A., Pang, H., Dellinger, A. E., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley‐Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2013) · Hepatology · doi:10.1002/hep.26661 · Cited by 316 · see citing works

Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

Karsdal, M. A., Manon‐Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N. U. B., Bay‐Jensen, A., Bager, C. L., Krag, A. A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 261 · see citing works

Resistance to Carbon Tetrachloride-Induced Hepatotoxicity in Mice Which Lack CYP2E1 Expression

Wong, F. W.-Y., Chan, W. Y., & Lee, S. S. T. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8547 · Cited by 251 · see citing works

Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1

Kim, Y.-S., Ratziu, V., Choi, S.-G., Lalazar, A., Theiss, G., Dang, Q., Kim, S., & Friedman, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33750 · Cited by 249 · see citing works

Differential gene expression in periportal and perivenous mouse hepatocytes

Braeuning, A., Ittrich, C., Köhle, C., Hailfinger, S., Bonin, M., Buchmann, A., & Schwarz, M. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05503.x · Cited by 240 · see citing works

Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients

Teufel, A., Itzel, T., Erhart, W., Brosch, M., Wang, X. Y., Kim, Y. O., von Schönfels, W., Herrmann, A., Brückner, S., Stickel, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.051 · Cited by 229 · see citing works

MiR-122 in hepatic function and liver diseases

Hu, J., Xu, Y., Hao, J., Wang, S., Li, C., & Meng, S. (2012) · Protein & Cell · doi:10.1007/s13238-012-2036-3 · Cited by 208 · see citing works

Glucocorticoids Promote Chondrogenic Differentiation of Adult Human Mesenchymal Stem Cells by Enhancing Expression of Cartilage Extracellular Matrix Genes

Derfoul, A., Perkins, G. L., Hall, D. J., & Tuan, R. S. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0415 · Cited by 202 · see citing works

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

Fujii, T., Fuchs, B. C., Yamada, S., Lauwers, G. Y., Kulu, Y., Goodwin, J. M., Lanuti, M. D., & Tanabe, K. K. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-79 · Cited by 202 · see citing works

Extracellular Matrix and Liver Disease

Arriazu, E., de Galarreta, M. R., Cubero, F. J., Varela‐Rey, M., de Obanos, M. P. P., Leung, T. M., Lopategi, A., Benedicto, A., Abraham‐Enachescu, I., & Nieto, N. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5697 · Cited by 197 · see citing works

The epidemiology, pathogenesis and histopathology of fatty liver disease

Levene, A., & Goldin, R. D. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04145.x · Cited by 192 · see citing works

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

Baker, S. S., Baker, R. D., Liu, W., Nowak, N. J., & Zhu, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009570 · Cited by 184 · see citing works

Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation

Liu, Y., Liu, H., Meyer, C., Li, J., Nadalin, S., Königsrainer, A., Weng, H., Dooley, S., & ten Dijke, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478685 · Cited by 181 · see citing works

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Verrijken, A., Francque, S., Mertens, I. L., Prawitt, J., Caron, S., Hubens, G., Marck, E. V., Staels, B., Michielsen, P. P., & Gaal, L. V. (2013) · Hepatology · doi:10.1002/hep.26510 · Cited by 180 · see citing works

Cell-Type-Resolved Quantitative Proteomics of Murine Liver

Azimifar, S. B., Nagaraj, N., Cox, J., & Mann, M. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.002 · Cited by 173 · see citing works

Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Lake, A. D., Novak, P., Fisher, C. D., Jackson, J. P., Hardwick, R. N., Billheimer, D. D., Klimecki, W. T., & Cherrington, N. J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040592 · Cited by 167 · see citing works

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis

Kita, Y., Takamura, T., Misu, H., Ota, T., Kurita, S., Takeshita, Y., Uno, M., Nagata, N., Kato, K., Ando, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043056 · Cited by 153 · see citing works

Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans

Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Òdena, G., Lu, J. Z., Tanaka, N., Matsusue, K., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.009 · Cited by 145 · see citing works

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141 · see citing works

Dermatopontin, a Novel Player in the Biology of the Extracellular Matrix

Okamoto, O., & Fujiwara, S. (2006) · Connective Tissue Research · doi:10.1080/03008200600846564 · Cited by 141 · see citing works

Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis

Krishnan, A., Li, X., Kao, W.-Y., Viker, K., Butters, K. A., Masuoka, H. C., Knudsen, B. E., Gores, G. J., & Charlton, M. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.121 · Cited by 135 · see citing works

Regulation of hepatic stellate cells by connective tissue growth factor

Huang, G. (2012) · Frontiers in bioscience · doi:10.2741/4067 · Cited by 135 · see citing works

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments

Sasaki, A., Nitta, H., Otsuka, K., Umemura, A., Baba, S., Obuchi, T., & Wakabayashi, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00164 · Cited by 133 · see citing works

Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats

Stärkel, P., Sempoux, C. L., Leclercq, I. A., Hérin, M., Deby, C. M. T., Desager, J., & Horsmans, Y. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00360-x · Cited by 132 · see citing works

A Cell-type-resolved Liver Proteome

Ding, C., Li, Y., Guo, F., Jiang, Y., Ying, W., Li, D., Yang, D. C., Xia, X., Liu, W., Zhao, Y., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060145 · Cited by 123 · see citing works

Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis

Dattaroy, D., Pourhoseini, S., Das, S., Alhasson, F. A., Seth, R. K., Nagarkatti, M., Michelotti, G. A., Diehl, A. M., & Chatterjee, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2014 · Cited by 116 · see citing works

Dermatopontin interacts with transforming growth factor β and enhances its biological activity

Okamoto, O., Fujiwara, S., Abé, M., & Sato, Y. (1999) · Biochemical Journal · doi:10.1042/bj3370537 · Cited by 115 · see citing works

Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis

Starmann, J., Fälth, M., Spindelboeck, W., Lanz, K.-L., Lackner, C., Zatloukal, K., Trauner, M. A., & Sültmann, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046584 · Cited by 112 · see citing works

Instructive Roles of Extracellular Matrix on Autophagy

Neill, T., Schaefer, L., & Iozzo, R. V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.05.010 · Cited by 112 · see citing works

Disease signatures are robust across tissues and experiments

Dudley, J. T., Tibshirani, R. J., Deshpande, T., & Butte, A. J. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.66 · Cited by 110 · see citing works

Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells

Morán‐Salvador, E., Titos, E., Rius, B., González‐Périz, A., García‐Alonso, V., López‐Vicario, C., Miquel, R., Barak, Y., Arroyo, V., & Clària, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.023 · Cited by 109 · see citing works

Targeted Disruption of Dermatopontin Causes Abnormal Collagen Fibrillogenesis

Takeda, U., Utani, A., Wu, J., Shinkai, H., Adachi, E., Koseki, H., Taniguchi, M., MATSUMOTΟ, T., OHASHI, T., & Sato, M. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01863.x · Cited by 104 · see citing works

Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways

Seifert, L., Deutsch, M., Alothman, S., Alqunaibit, D., Werba, G., Pansari, M., Pergamo, M., Ochi, A., Torres-Hernandez, A., Levie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.058 · Cited by 95 · see citing works

Paracrine activation of hepatic stellate cells in platelet‐derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma

Wright, J. H., Johnson, M. M., Shimizu‐Albergine, M., Bauer, R. L., Hayes, B. J., Surapisitchat, J., Hudkins, K. L., Riehle, K. J., Johnson, S. C., Yeh, M. M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28421 · Cited by 68 · see citing works

Dermatopontin Interacts with Fibronectin, Promotes Fibronectin Fibril Formation, and Enhances Cell Adhesion

Kato, A., Okamoto, O., Ishikawa, K., Sumiyoshi, H., Matsuo, N., Yoshioka, H., Nomizu, M., Shimada, T., & Fujiwara, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179762 · Cited by 67 · see citing works

PPARα Inhibits TGF-β–Induced β 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4

Kintscher, U., Lyon, C. J., Wakino, S., Bruemmer, D., Feng, X., Goetze, S., Graf, K., Moustakas, A., Staels, B., Fleck, E., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000046017.96083.34 · Cited by 66 · see citing works

Extracellular Matrix 22-kDa Protein Interacts with Decorin Core Protein and Is Expressed in Cutaneous Fibrosis

Okamoto, O., Suzuki, Y., Kimura, S., & Shinkai, H. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021194 · Cited by 50 · see citing works

Characterization of Hepatocellular Carcinoma Related Genes and Metabolites in Human Nonalcoholic Fatty Liver Disease

Clarke, J., Novák, P., Lake, A. D., Shipkova, P. A., Aranı́bar, N., Robertson, D. G., Severson, P. L., Reily, M. D., Futscher, B. W., Lehman‐McKeeman, L. D., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2873-9 · Cited by 45 · see citing works

DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling

Fu, Y., Feng, M., Yu, J., Ma, M., Liu, X., Li, J., Yang, X., Wang, Y., Zhang, Y., Ao, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2239 · Cited by 44 · see citing works

Regulation of Hepatic Six Transmembrane Epithelial Antigen of Prostate 4 (STEAP4) Expression by STAT3 and CCAAT/Enhancer-binding Protein α

Ramadoss, P., Chiappini, F., Bilban, M., & Hollenberg, A. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066936 · Cited by 40 · see citing works

Undulin Rna and Protein Expression in Normal and Fibrotic Human Liver

Milani, S., Grappone, C., Pellegrini, G., Schuppan, D., Herbst, H., Calabró, A., Casini, A., Pinzani, M., & Surrenti, C. (1994) · Hepatology · doi:10.1002/hep.1840200420 · Cited by 39 · see citing works

Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis

Lee, J. I., Wright, J. H., Johnson, M. M., Bauer, R. L., Sorg, K., Yuen, S. Y., Hayes, B. J., Nguyen, L., Riehle, K. J., & Campbell, J. S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00423.2014 · Cited by 36 · see citing works

Gene expression profiling of non‐alcoholic steatohepatitis using gene set enrichment analysis

Yoneda, M., Endo, H., Mawatari, H., Nozaki, Y., Fujita, K., Akiyama, T., Higurashi, T., Uchiyama, T., Yoneda, K., Takahashi, H., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00399.x · Cited by 35 · see citing works

Histamine Receptor H1 and Dermatopontin: New Downstream Targets of the Vitamin D Receptor

Pochampally, R. R., Ylöstalo, J., Penfornis, P., Matz, R., Smith, J. R., & Prockop, D. J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070605 · Cited by 30 · see citing works

Dermatopontin Regulates Fibrin Formation and Its Biological Activity

Wu, W., Okamoto, O., Kato, A., Matsuo, N., Nomizu, M., Yoshioka, H., & Fujiwara, S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.305 · Cited by 15 · see citing works

Identification of fibronectin binding sites in dermatopontin and their biological function

Kato, A., Okamoto, O., Wu, W., Matsuo, N., Kumai, J., Yamada, Y., Katagiri, F., Nomizu, M., & Fujiwara, S. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.07.003 · Cited by 13 · see citing works

Functional peptide of dermatopontin produces fibrinogen fibrils and modifies its biological activity

Wu, W., Okamoto, O., Kato, A., Matsuo, N., Kumai, J., Nomizu, M., & Fujiwara, S. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.07.002 · Cited by 7 · see citing works

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Govaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4448 · Cited by 479 · see citing works

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316 · see citing works

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

Suppli, M. P., Rigbolt, K. T. G., Veidal, S. S., Heebøll, S., Eriksen, P. L., Demant, M., Bagger, J. I., Nielsen, J. C., Oró, D., Thrane, S. W., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00358.2018 · Cited by 288 · see citing works

Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome

Rom, O., Liu, Y., Liu, Z., Zhao, Y., Wu, J., Ghrayeb, A., Villacorta, L., Fan, Y., Chang, L., Wang, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2841 · Cited by 286 · see citing works

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity

Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238 · see citing works

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

Liang, Q., Teoh, N., Xu, L., Pok, S., Li, X., Chu, E. S., Chiu, J., Dong, L., Arfianti, A., Haigh, W. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06931-6 · Cited by 223 · see citing works

Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease

Hoang, S. A., Oseini, A. M., Feaver, R. E., Cole, B. K., Asgharpour, A., Vincent, R. J., Siddiqui, M. S., Lawson, M. J., Day, N., Taylor, J. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48746-5 · Cited by 191 · see citing works

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

Raverdy, V., Tavaglione, F., Chatelain, E., Lassailly, G., Vincentis, A. D., Gentilucci, U. V., Qadri, S. U., Caiazzo, R. J., Verkindt, H., Saponaro, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03283-1 · Cited by 176 · see citing works

The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury

Raftar, S. K. A., Ashrafian, F., Yadegar, A., Lari, A., Moradi, H. R., Shahryari, A., Azimirad, M., Alavifard, H., Mohsenifar, Z., Davari, M., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00484-21 · Cited by 166 · see citing works

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 163 · see citing works

Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

Haas, J. T., Vonghia, L., Mogilenko, D. A., Verrijken, A., Molendi-Coste, O., Fleury, S., Deprince, A., Nikitin, A., Woitrain, E., Ducrocq-Geoffroy, L., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0076-1 · Cited by 155 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

A human multi-lineage hepatic organoid model for liver fibrosis

Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149 · see citing works

QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis

You, K., Wang, L., Chou, C., Liu, K., Nakata, T., Jaiswal, A., Yao, J., Lefkovith, A. J., Omar, A. S., Perrigoue, J., et al. (2020) · Science · doi:10.1126/science.abb6896 · Cited by 147 · see citing works

Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Loft, A., Alfaro, A. J., Schmidt, S. F., Pedersen, F. B., Terkelsen, M. K., Puglia, M., Chow, K. K., Feuchtinger, A., Troullinaki, M., Maida, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.005 · Cited by 129 · see citing works

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Yu, J., Zhu, C., Wang, X., Kim, K., Bartolome, A., Dongiovanni, P., Yates, K. P., Valenti, L., Carrer, M., Sadowski, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1692 · Cited by 132 · see citing works

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Fujiwara, N., Kubota, N., Crouchet, É., Koneru, B., Marquez, C. A., Jajoriya, A. K., Panda, G., Qian, T., Zhu, S., Goossens, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4474 · Cited by 124 · see citing works

Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease

Lefèbvre, P., & Staels, B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00538-6 · Cited by 114 · see citing works

CD4+ T cell activation and inflammation in NASH-related fibrosis

Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 110 · see citing works

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

Baselli, G., Dongiovanni, P., Rametta, R., Meroni, M., Pelusi, S., Maggioni, M., Badiali, S., Pingitore, P., Maurotti, S., Montalcini, T., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319226 · Cited by 106 · see citing works

Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury

Terkelsen, M. K., Bendixen, S. M., Hansen, D., Scott, E. A. H., Moeller, A. F., Nielsen, R., Mandrup, S., Schlosser, A. G., Andersen, T. L., Sørensen, G. L., et al. (2020) · Hepatology · doi:10.1002/hep.31215 · Cited by 104 · see citing works

Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi

Xiong, X., Wang, Q., Wang, S., Zhang, J., Liu, T., Guo, L., Yu, Y., & Lin, J. D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.004 · Cited by 100 · see citing works

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95 · see citing works

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD

Pantano, L., Agyapong, G., Shen, Y., Zhuo, Z., Fernández-Albert, F., Rust, W., Knebel, D., Hill, J., Boustany, C., Doerner, J. F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96966-5 · Cited by 94 · see citing works

Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway

Jiang, B., Wang, D., Hu, Y., Li, W., Liu, F., Zhu, X., Li, X., Zhang, H., Bai, H., Yang, Q., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101462 · Cited by 90 · see citing works

Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease

Oishi, Y., & Manabe, I. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00069 · Cited by 73 · see citing works

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes

Gerhard, G. S., Legendre, C., Still, C. D., Chu, X., Petrick, A. T., & DiStefano, J. K. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00122 · Cited by 70 · see citing works

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Fujiwara, N., Kobayashi, M., Fobar, A. J., Hoshida, A., Marquez, C. A., Koneru, B., Panda, G., Taguri, M., Qian, T., Raman, I., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.017 · Cited by 70 · see citing works

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)

Vandel, J., Dubois‐Chevalier, J., Gheeraert, C., Derudas, B., Raverdy, V., Thuillier, D., Gaal, L., Francque, S., Pattou, F., Staels, B., et al. (2021) · Hepatology · doi:10.1002/hep.31312 · Cited by 61 · see citing works

Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice

Higuchi, S., Ahmad, T. R., Argueta, D. A., Perez, P. A., Zhao, C., Schwartz, G. J., DiPatrizio, N. V., & Haeusler, R. A. (2020) · Gut · doi:10.1136/gutjnl-2019-319693 · Cited by 65 · see citing works

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα

Liang, N., Damdimopoulos, A., Goñi, S., Huang, Z.-Q., Vedin, L.-L., Jakobsson, T., Giudici, M., Ahmed, O., Pedrelli, M., Barilla, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09524-z · Cited by 56 · see citing works

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 56 · see citing works

Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction

Du, K., Umbaugh, D. S., Wang, L., Jun, J. H., Dutta, R. K., Oh, S., Ren, N., Zhang, Q., Ko, D. C., Ferreira, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57616-w · Cited by 60 · see citing works

MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists

Cooreman, M. P., Vonghia, L., & Francque, S. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111688 · Cited by 52 · see citing works

Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis

Bobowski, M., Boulet, C., Zummo, F. P., Dubois‐Chevalier, J., Gheeraert, C., Saleh, M. B., Strub, J., Farce, A., Ploton, M., Guille, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33063-9 · Cited by 47 · see citing works

A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells

Kasahara, N., Imi, Y., Amano, R., Shinohara, M., Okada, K., Hosokawa, Y., Imamori, M., Tomimoto, C., Kunisawa, J., Kishino, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-46404-5 · Cited by 50 · see citing works

Dermatopontin, A Novel Adipokine Promoting Adipose Tissue Extracellular Matrix Remodelling and Inflammation in Obesity

Unamuno, X., Gómez‐Ambrosi, J., Ramírez, B., Rodrı́guez, A., Becerril, S., Valentí, V., Moncada, R., Silva, C., Salvador, J., Frühbeck, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041069 · Cited by 48 · see citing works

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, D., Irvine, K. M., Lukowski, S. W., Horsfall, L. U., Loh, Z., Clouston, A. D., Patel, P. J., Fagan, K. J., Iyer, A., Lampe, G., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120274 · Cited by 47 · see citing works

hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis

Xiong, J., Liu, T., Mi, L., Kuang, H., Xiong, X., Chen, Z., Li, S., & Lin, J. D. (2019) · Hepatology · doi:10.1002/hep.30921 · Cited by 46 · see citing works

Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study

Morrison, M. C., Kleemann, R., van Koppen, A., Hanemaaijer, R., & Verschuren, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00132 · Cited by 44 · see citing works

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

Wargny, M., Ducluzeau, P., Petit, J., May, C. L., Smati, S., Arnaud, L., Pichelin, M., Bouillet, B., Lannes, A., Blanchet, O., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.008 · Cited by 41 · see citing works

Multi-Omics Insights into Functional Alterations of the Liver in Insulin-Deficient Diabetes Mellitus

Backman, M., Flenkenthaler, F., Blutke, A., Dahlhoff, M., Ländström, E., Renner, S., Philippou‐Massier, J., Krebs, S., Rathkolb, B., Prehn, C. P., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.011 · Cited by 40 · see citing works

Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies

Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., Parthasarathy, G., Malhi, H., Malmierca-Merlo, P., de la Iglesia-Vayá, M., & Garcia‐García, F. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00368-1 · Cited by 39 · see citing works

GARP on hepatic stellate cells is essential for the development of liver fibrosis

Zhang, X., Sharma, P., Maschmeyer, P., Hu, Y., Lou, M., Kim, J., Fujii, H., Unutmaz, D., Schwabe, R. F., & Winau, F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.043 · Cited by 39 · see citing works

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Kannt, A., Madsen, A. N., Kammermeier, C., Elvert, R., Klöckener, T., Bossart, M., Haack, T., Evers, A., Lorenz, K., Hennerici, W., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14035 · Cited by 37 · see citing works

PPARα and NCOR/SMRT corepressor network in liver metabolic regulation

Kang, Z., & Fan, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000055rr · Cited by 37 · see citing works

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease

Day, K., Seale, L. A., Graham, R. M., & Cardoso, B. R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.744825 · Cited by 37 · see citing works

Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma

Teo, J. M. N., Chen, Z., Chen, W., Tan, R. J. Y., Cao, Q., Chu, Y., Ma, D., Chen, L., Yu, H., Lam, K.-H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20241442 · Cited by 31 · see citing works

Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies

Bourganou, M. V., Chondrogianni, M. E., Kyrou, I., Flessa, C., Chatzigeorgiou, A., Oikonomou, E. K., Lambadiari, V., Randeva, H. S., & Kassi, E. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041589 · Cited by 31 · see citing works

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan

Park, J. G., Mok, J. S., Han, Y. I., Park, T. S., Kang, K. W., Choi, C. S., Park, J., & Park, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40322-1 · Cited by 30 · see citing works

Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis

Mercado-Gómez, M., Lopitz‐Otsoa, F., Azkargorta, M., Serrano‐Maciá, M., Lachiondo‐Ortega, S., Goikoetxea‐Usandizaga, N., Agudo, R. R., Fernández‐Ramos, D., Bizkarguenaga, M., Juan, V. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239043 · Cited by 29 · see citing works

Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control

Montgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Miotto, P. M., Karimkhanloo, H., Huang, C., Schittenhelm, R. B., Don, A. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28889-2 · Cited by 29 · see citing works

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

Sen, P., Govaere, O., Sinioja, T., McGlinchey, A., Geng, D., Ratziu, V., Bugianesi, E., Schattenberg, J. M., Vidal-Puig, A., Allison, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104949 · Cited by 28 · see citing works

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP

Ye, D., Wang, Y., Deng, X., Zhou, X., Liu, D., Zhou, B., Zheng, W., Wang, X., & Fang, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05657-8 · Cited by 28 · see citing works

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Das, S. R., Finney, A. C., Anand, S. K., Rohilla, S., Liu, Y., Pandey, N. O., Ghrayeb, A., Kumar, D., Núñez, K., Liu, Z., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01134-4 · Cited by 26 · see citing works

Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure

Pan, Q., Ai, W., Chen, Y., Kim, D. M., Shen, Z., Yang, W., Jiang, W., Sun, Y., Safe, S. H., & Guo, S. (2023) · Diabetes · doi:10.2337/db23-0180 · Cited by 24 · see citing works

Hepatic adaptation to chronic metabolic stress primes tumorigenesis

Tzouanas, C., Shay, J. E. S., Sherman, M. S., Rubin, A. J., Mead, B. E., Dao, T. T., Tao, J.-Y., Lehrich, B. M., Eng, G., Patterson-Fortin, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.031 · Cited by 22 · see citing works

Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model

Kostadinova, R. M., Ströbel, S., Chen, L., Fiaschetti‐Egli, K., Gadient, J., Pawlowska, A., Petitjean, L., Bieri, M., Thoma, E., & Petitjean, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-55438-2 · Cited by 21 · see citing works

A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease

Song, Y., Zhang, J., Wang, H., Guo, D., Yuan, C., Liu, B., Zhong, H., Li, D., & Li, Y. (2021) · Adipocyte · doi:10.1080/21623945.2021.1970341 · Cited by 22 · see citing works

Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study

Albadawy, R. M., Agwa, S. H. A., Khairy, E., Saad, M., Touchy, N. E., Othman, M. O., & Matboli, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091248 · Cited by 22 · see citing works

High-Protein Mulberry Leaves Improve Glucose and Lipid Metabolism via Activation of the PI3K/Akt/PPARα/CPT-1 Pathway

Shan, Z., Zhang, H., He, C., An, Y., Huang, Y., Fu, W., Wang, M., Du, Y., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168726 · Cited by 21 · see citing works

Emerging Insights into the Role of BDNF on Health and Disease in Periphery

Ichimura‐Shimizu, M., Kurrey, K., Miyata, M., Dezawa, T., Tsuneyama, K., & Kojima, M. (2024) · Biomolecules · doi:10.3390/biom14040444 · Cited by 20 · see citing works

Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content

Mazzini, G. S., Khoraki, J., Browning, M. G., Wu, J., Zhou, H., Price, E. T., Wolfe, L. G., Mangino, M. J., & Campos, G. M. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-04908-3 · Cited by 19 · see citing works

Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome

Zanoni, P., Panteloglou, G., Othman, A., Haas, J. T., Meier, R., Rimbert, A., Futema, M., Khalil, Y. A., Nørrelykke, S. F., Rzepiela, A. J., et al. (2022) · Research at the University of Copenhagen (University of Copenhagen) · doi:10.1161/circresaha.120.318141 · Cited by 18 · see citing works

Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis

Mazzini, G. S., Khoraki, J., Dozmorov, M. G., Browning, M. G., Wijesinghe, D. S., Wolfe, L. G., Gurski, R. R., & Campos, G. M. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3938-z · Cited by 18 · see citing works

Expression of Fibrosis-Related Genes in Liver and Kidney Fibrosis in Comparison to Inflammatory Bowel Diseases

Jerala, M., Hauptman, N., Kojc, N., & Zidar, N. (2022) · Cells · doi:10.3390/cells11030314 · Cited by 18 · see citing works

Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease

Ilieva, M. S., Dao, J., Miller, H. E., Madsen, J. H., Bishop, A. J. R., Kauppinen, S., & Uchida, S. (2022) · Non-Coding RNA · doi:10.3390/ncrna8040056 · Cited by 17 · see citing works

Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease

Dubois, V., Lefèbvre, P., Staels, B., & Eeckhoute, J. (2024) · Gut · doi:10.1136/gutjnl-2023-331741 · Cited by 17 · see citing works

Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder

Yamaji, K., Iwabuchi, S., Tokunaga, Y., Hashimoto, S., Yamane, D., Toyama, S., Kono, R., Kitab, B., Tsukiyama–Kohara, K., Osawa, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115379 · Cited by 14 · see citing works

Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model

Arconzo, M., Piccinin, E., Pasculli, E., Cariello, M., Loiseau, N., Bertrand‐Michel, J., Guillou, H., Matrella, M. L., Villani, G., & Moschetta, A. (2024) · Liver International · doi:10.1111/liv.16052 · Cited by 14 · see citing works

HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis

Yang, Y., Liu, X., Chen, H., Wang, P., Yao, S., Zhou, B., Yin, R., Li, C., Wu, C., Yang, X., et al. (2022) · FEBS Journal · doi:10.1111/febs.16430 · Cited by 14 · see citing works

Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

Catalán, V., Domench, P., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Mentxaka, A., Rodrı́guez, A., Valentí, V., Moncada, R., Baixauli, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169222 · Cited by 14 · see citing works

Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease

Goossens, N., & Jornayvaz, F. R. (2017) · Nutrients · doi:10.3390/nu9101077 · Cited by 14 · see citing works

Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice

Henry, D., Baugé, E., Hennuyer, N., Ory, K., Derudas, B., Vallez, E., Deprince, A., Lefèbvre, P., Haas, J. T., Staels, B., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adj8192 · Cited by 13 · see citing works

Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD

Johanns, M., Haas, J. T., Raverdy, V., Vandel, J., Chevalier-Dubois, J., Guille, L., Derudas, B., Legendre, B., Caiazzo, R. J., Verkindt, H., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100948 · Cited by 13 · see citing works

Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery

Fu, C., Zhou, Y. J., Wu, Z., Li, Y., Zhou, W., & Wang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.611213 · Cited by 13 · see citing works

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

Boeckmans, J., Gatzios, A., Heymans, A., Rombaut, M., Rogiers, V., Kock, J. D., Vanhaecke, T., & Rodrigues, R. M. (2022) · Cells · doi:10.3390/cells11050893 · Cited by 13 · see citing works

SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH

Cano, L., Desquilles, L., Ghukasyan, G., Angenard, G., Landreau, C., Corlu, A., Clément, B., Turlin, B., Ferrec, E. L., Aninat, C., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100936 · Cited by 12 · see citing works

Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis

Lu, Y., Wu, Q., Liao, J., Zhang, S., Lü, K., Yang, S., Wu, Y., Dong, Q., Yuan, J. T., Zhao, N., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2913 · Cited by 12 · see citing works

Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis

Li, Y., Yuan, S., Yin, J.-Y., Yang, K., Zhou, X.-G., Xie, W., & Wang, Q. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i7.1265 · Cited by 12 · see citing works

Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives

Chen, Y., Bian, S., & Le, J. (2025) · Genes · doi:10.3390/genes16040399 · Cited by 11 · see citing works

Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD

Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., Koellmer, C., Al‐Hasani, H., Lehr, S., Müller‐Wieland, D., Knebel, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126873 · Cited by 11 · see citing works

A Positive Loop Formed by SOX11 and Periostin Upregulates TGF-β Signals Leading to Skin Fibrosis

Nanri, Y., Nunomura, S., Honda, Y., Takedomi, H., Yamaguchi, Y., & Izuhara, K. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.12.008 · Cited by 10 · see citing works

Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology

Stiglund, N., Hagström, H., Stal, P. I., Cornillet, M., & Björkström, N. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186097 · Cited by 10 · see citing works

Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression

Piras, I. S., & DiStefano, J. K. (2024) · Life Science Alliance · doi:10.26508/lsa.202302517 · Cited by 9 · see citing works

Identification of HTRA1, DPT and MXRA5 as potential biomarkers associated with osteoarthritis progression and immune infiltration

Sun, Y., Yang, H., Guo, J., Du, J., Han, S., & Yang, X. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07758-7 · Cited by 9 · see citing works

Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells

Sharma, R., Ali, T., & Kaur, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-21084-9 · Cited by 9 · see citing works

Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift

Migdał, M., Tralle, E., Nahia, K. A., Bugajski, Ł., Kedzierska, K., Garbicz, F., Piwocka, K., Winata, C. L., & Pawlak, M. (2021) · BMC Genomics · doi:10.1186/s12864-021-08173-1 · Cited by 9 · see citing works

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy

Chen, S., Zeng, Q., Cai, X., Xue, J., Yin, G., Song, P., Tang, L., Klein, C., Tacke, F., Guillot, A., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.98362 · Cited by 8 · see citing works

EMP1 as a Potential Biomarker in Liver Fibrosis: A Bioinformatics Analysis

Chen, X., Lv, X., Han, M., Hu, Y., Zheng, W., Xue, H., Li, Z., Li, K., & Tan, W. (2023) · Gastroenterology Research and Practice · doi:10.1155/2023/2479192 · Cited by 8 · see citing works

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Dijck, E. V., Laere, S. V., Logie, E., Timmermans, S., Fransén, E., Ibrahim, J., Kendall, T. J., Fallowfield, J. A., Mateiu, L. M., Libert, C., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01945-6 · Cited by 7 · see citing works

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

Chen, X., Zhang, L., Wang, Y., Li, R., Yang, M., & Gao, L. (2022) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2022-0006 · Cited by 7 · see citing works

Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease

Ye, H., Sun, M., Su, M., Chen, D., Liu, H., Ma, Y., Luo, W., Li, H., & Xu, F. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1070605 · Cited by 8 · see citing works

Bariatric Surgery Affects Plasma Levels of Alanine Aminotransferase Independent of Weight Loss: A Registry-Based Study

Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Carmi, S., Schyr, R. B., Romano‐Zelekha, O., & Ben‐Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122724 · Cited by 7 · see citing works

Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis

Yu, R., Huang, Y., Hu, X., & Chen, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32783 · Cited by 5 · see citing works

Tyrosine-sulfated dermatopontin shares multiple binding sites and recognition determinants on triple-helical collagens with proteins implicated in cell adhesion and collagen folding, fibrillogenesis, cross-linking, and degradation

Jensen, M. M., Bonna, A., Frederiksen, S. J., Hamaia, S. W., Højrup, P., Farndale, R. W., & Karring, H. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140771 · Cited by 5 · see citing works

Identification of hub biomarkers in liver post-metabolic and bariatric surgery using comprehensive machine learning (experimental studies)

Li, Z., Wang, L., Tian, C., Wang, Z., Zhao, H., Yao, Q., Chen, W., Wuyun, Q., Amin, B., Lian, D., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002179 · Cited by 4 · see citing works

Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesityPreprint

Hung, Y.-H., Sritharan, R., Vohl, M., Ilkayeva, O., Biertho, L. D., Tchernof, A., White, P. J., & Sethupathy, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.20.457162 · Cited by 4 · see citing works

Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index

Cheikhi, A., Johnson, Z. I., Julian, D. R., Wheeler, S., Feghali‐Bostwick, C. A., Conley, Y. P., Lyons‐Weiler, J., & Yates, C. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240986 · Cited by 2 · see citing works

TRAF2 decreases lipid accumulation in hepatocytes under endoplasmic reticulum stress

Li, S., Li, Y., Wang, X., Xia, Z., & Hu, R. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023094 · Cited by 2 · see citing works

The PPARa-regulated dermatopontin is an important contributor to the liver fibrotic response in mouse models and has relevance to fibrosis progression in non-alcoholic fatty liver disease patients

Lefèbvre, P., Francque, S., Lalloyer, F., Baugé, E., Verrijken, A., & Staels, B. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30606-2

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141 · see citing works

Inhibition of thrombospondin-1 and the signal transducer and activator of transcription 3 as independent approaches to attenuate hepatic fibrosis

Min-DeBartolo, J. H. (2019) · OpenBU (Boston University)

Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice

Du, M., Wang, X., Yuan, L., Liu, B., Mao, X., Huang, D., Yang, L., Huang, K., Zhang, F., Wang, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.030 · Cited by 41 · see citing works

The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression

Schulien, I., Hockenjos, B., Schmitt-Graeff, A., Perdekamp, M. G., Follo, M., Thimme, R., & Hasselblatt, P. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0239-8 · Cited by 111 · see citing works